What is Mclab?
Molecular Cloning Laboratories (MCLAB) is a BioTech firm headquartered in South San Francisco, specializing in a comprehensive suite of molecular biology and biotechnology services and products. The company's core offerings encompass diverse DNA services, including sequencing, PCR cloning, and Next-Generation Sequencing (NGS) services. Additionally, MCLAB provides a range of products such as enzymes, nucleic acid purification kits, and protein purification solutions. Primarily serving researchers and professionals in the life sciences, MCLAB equips them with essential tools and reagents for genetic analysis and manipulation, thereby supporting advancements in genomics and proteomics.
How much funding has Mclab raised?
Mclab has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Mclab?
The substantial late-stage funding Mclab has attracted indicates a strategic push towards scaling operations and potentially expanding its market reach. This capital infusion is likely to fuel further research and development, enhance its service portfolio, and strengthen its position in the competitive life sciences market. The company's focus on foundational molecular biology tools suggests a trajectory aimed at solidifying its role as a key supplier for genomic and proteomic research.
See full Mclab company page
